Submissions from 2022
Strategies for Reducing Vascular and Bleeding Risk for Percutaneous Left Ventricular Assist Device-supported High-risk Percutaneous Coronary Intervention., George W Vetrovec, Amir Kaki, Jason Wollmuth, and Thom G Dahle
Geno4ME: establishment of an equitable whole-genome sequencing-based platform for clinical screening in a large healthcare system, Josiah Wagner, I A. Lucas-Beckett, K R. Emery, B A. Cosgrove, John T. Welle, K Jade, N D. Wagner, J Rinaldi, Lindsay Dickey, K G. Jones, L Yuan, E M. Shull, J Clemens, Keri Vartanian, A T. Magis, M B. Campbell, Brian Piening, Carlo Bifulco, and Ora K. Gordon
Clinical Performance of Comprehensive Genomic Profiling Using a Wide Range of Input Quantities and Solid Tumor Tissue Types, Josiah Wagner, S Reynolds, A Dowdell, E Shull, J Welle, M Pukay, R Rattray, C Moung-Wen, T Ward, M Campbell, C Bifulco, and B Piening
Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction., Dennis D Wang, Sophia Airhart, Bo Zhou, Laura M Shireman, Siyi Jiang, Carolina Melendez Rodriguez, James N Kirkpatrick, Danny D Shen, Rong Tian, and Kevin D O'Brien
Streamlining Solid Tumor Comprehensive Genomic Profiling Workflows Using Learned Variant and Sequencing Noise Autoclassification, Thomas Ward, S Reynolds, J Wagner, N Naidoo, E Shull, John Welle, R Rattray, C Moung-Wen, Mary Campbell, Brian Piening, and Carlo Bifulco
Conclusions and recommendations of an AHPBA-commissioned assessment of strengths, weaknesses, opportunities, and threats facing fellowship training in HPB surgery., Susanne G Warner, Michele Babicky, Adnan Alseidi, Brendan Visser, and AHPBA SWOT Taskforce
Identification of clinically actionable biomarkers via routine comprehensive genomic profiling across a large community health system, Roshanthi Weerasinghe, Ryan Meng, Alexa K Dowdell, Bela Bapat, Ann Vita, Brock Schroeder, Alisha Stein, Lauren Harold, Mark Schmidt, Shu-Ching Chang, Thomas R. Ward, Josiah T Wagner, Stanley Piotrowski, Phillip G. Febbo, Carlo Bifulco, and Brian D. Piening
Identification of clinically actionable biomarkers via routine comprehensive genomic profiling across a large community health system., Rosohanthi K. Weersinghe, Ryan Meng, Alexa K. Dowdell, Bela Bapat, Ann Vita, Brock Schroeder, Alisha Stein, Lauren Harold, Mark Schmidt, Shu-Ching Chang, Thomas Ward, Josiah Wagner, Stanley Piotrowski, Phillip G. Febbo, Carlo Bifulco, and Brian Piening
Enriching for tumor-reactive CD8 TIL using CD39/103 markers: Clinical implications, A Weinberg
Isolating/Expanding the Entire TIL Repertoire of Tumor-Reactive CD8 T Cells for Cell Therapy in H&N Cancer, Andrew Weinberg
Identifying tumor-reactive CD8+ TIL in patients with solid malignancies: clinical implications, Andrew D Weinberg
T Cell Agonists, Andrew D Weinberg
Design and Validation of a Whole-Genome Sequencing- Based Assay for Population Health, John Welle, Brian D. Piening, Josiah T Wagner, Isabelle Lucas-Beckett, T Ward, Benjamin Cosgrove, Eric Shull, R Rattray, Marina Pukay, M Ricks, Kimberly K Childers, Jennifer M Linehan, Mary Campbell, Ora K Gordon, and Carlo Bifulco
Design and Validation of a Whole-Genome SequencingBased Assay for Population Health, John Welle, Brian Piening, Josiah Wagner, I Lucas-Beckett, Thomas Ward, B Cosgrove, Eric Shull, R Rattray, Marina Pukay, Milena Ricks, K Childers, J Linehan, M Campbell, Ora Gordon, and Carlo Bifulco
Racial Differences in Patients with Spontaneous Coronary Artery Dissection: A Report of the ISCAD Registry, BJ Wells, LM Tam, and See all authors in comments
Migraine Headache in Patients with SCAD: A Report of the iSCAD Registry, BJ Wells, L Tam, and See all authors in comments
Adipocytes Encapsulating Telratolimod Recruit and Polarize Tumor-Associated Macrophages for Cancer Immunotherapy., Di Wen, Tingxizi Liang, Guojun Chen, Hongjun Li, Zejun Wang, Jinqiang Wang, Ruxing Fu, Xiao Han, Tianyuan Ci, Yuqi Zhang, Peter Abdou, Ruoxin Li, Linlin Bu, Gianpietro Dotti, and Zhen Gu
778 Botensilimab, a novel innate/adaptive immune activator, plus or minus balstilimab (anti-PD-1) in “cold” and I-O refractory metastatic solid tumors, Breelyn Wilky, Kim Margolin, Rachel E Sanborn, Steven O'Day, and See full list of authors in comments
2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee., Writing Committee, Tyler J Gluckman, Nicole M Bhave, Larry A Allen, Eugene H Chung, Erica S Spatz, Enrico Ammirati, Aaron L Baggish, Biykem Bozkurt, William K Cornwell, Kimberly G Harmon, Jonathan H Kim, Anuradha Lala, Benjamin D Levine, Matthew W Martinez, Oyere Onuma, Dermot Phelan, Valentina O Puntmann, Saurabh Rajpal, Pam R Taub, and Amanda K Verma
Current Clinical Trial Landscape of OX40 Agonists., Rashi Yadav and William L. Redmond
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial., Tomoko Yamazaki, Andrew J Gunderson, Miranda Gilchrist, Mark Whiteford, Maria X Kiely, Amanda Hayman, David O'Brien, Rehan Ahmad, Jeffrey V Manchio, Nathaniel E Fox, Kayla McCarty, Michaela Phillips, Evelyn Brosnan, Gina Vaccaro, Rui Li, Miklos Simon, Eric Bernstein, Mary McCormick, Lena Yamasaki, Yaping Wu, Ashley Drokin, Trevor Carnahan, Yy To, William L. Redmond, Brian Lee, Jeannie Louie, Eric Hansen, Matthew C Solhjem, Julie Cramer, Walter Urba, Michael J. Gough, Marka R Crittenden, and Kristina H Young
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial., Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, and Fabio Piscaglia
In-Hospital or Out-of-Hospital Cardiac Arrest is Associated with Worse Outcomes in Cardiogenic Shock, M Yin, Jacob Abraham, and See all authors in comments
In-Hospital or Out-of-Hospital Cardiac Arrest Is Associated with Worse Outcomes in Cardiogenic Shock, M Yin, Jacob Abraham, and See all authors in comments
A phase II trial of TGFβ type I receptor inhibitor, galunisertib, plus neoadjuvant chemoradiation in patients with locally advanced rectal cancer., Kristina H Young, Walter Urba, Michael J. Gough, Marka R Crittenden, and See full list of authors in comments
Intermittent Occlusion of the Superior Vena Cava Reduces Estimated Stressed Blood Volume in Patients with Acutely Decompensated Heart Failure, R Yousefzai, Jacob Abraham, M Kiernan, R Tedford, K Benzuly, R Karas, D Burkhoff, and NK Kapur
Intermittent Occlusion of the Superior Vena Cava Improves Urine Sodium Excretion in Patients with Acutely Decompensated Heart Failure, R Yousefzai, Jacob Abraham, and See all authors in comments
1171 CAN1012: a selective and potent TLR7 agonist with strong antitumoral properties mediated by localized innate immune activation, Henry Yu, William L. Redmond, Yoshinobu Koguchi, and See all authors in comments
Correction to: Ergonomic analysis of laparoscopic and robotic surgical task performance at various experience levels., Jorge G Zárate Rodriguez, Ahmed M Zihni, Ikechukwu Ohu, Jaime A Cavallo, Shuddhadeb Ray, Sohyung Cho, and Michael M Awad
Establishing core competencies, opportunities, roles and expertise for oncology social work, Brad Zebrack, Tara Schapmire, Shirley Otis-Green, Krista Nelson, Nina Miller, Donna Donna, and Michael Grignon
Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers., Chunhong Zheng, Joseph N Fass, Yi-Ping Shih, Andrew J Gunderson, Nelson Sanjuan Silva, Huayu Huang, Brady M Bernard, Venkatesh Rajamanickam, Joseph Slagel, Carlo B Bifulco, Brian Piening, Pippa H A Newell, Paul D Hansen, and Eric Tran
Antimicrobial Stewardship on Hospital Discharge: Pharmacist Intervention on Antibiotic Prescribing Practices, Jenny Zhu, Chinh Nguyen, and Brent Footer
Submissions from 2021
Mechanical Circulatory Support Devices in the Intensive Care Unit: Post-Implant Care and Management, Jacob Abraham (Ed) and Joseph E. Parrillo (Ed)
Chapter: Blood compatibility/hemolysis, Jacob Abraham
Heart Failure-Related Cardiogenic Shock: Pathophysiology, Evaluation and Management Considerations: Review of Heart Failure-Related Cardiogenic Shock., Jacob Abraham, Vanessa Blumer, Dan Burkhoff, Mohit Pahuja, Shashank S Sinha, Carolyn Rosner, Esther Vorovich, Gillian Grafton, Aaron Bagnola, Jaime A Hernandez-Montfort, and Navin K Kapur
Cardiogenic Shock Working Group Global Summit: Case Presentation, Jacob Abraham and Vidang P. Nguyen
Axillary transvalvular microaxial pump as bridge to transcatheter aortic valve replacement in cardiogenic shock, Jacob Abraham, Lian Wang, V Kumar, Eric B Kirker, and Kateri Spinelli
Portopulmonary rhapsody: everything you need to know about portopulmonary hypertension, Sophia Airhart
Recognizing and treating HFpEF: the biggest pulmonary arterial hypertension imitator!, Sophia Airhart
Assessing hemodynamic response to submaximal exercise in pulmonary arterial hypertension patients using an implantable hemodynamic monitor., Sophia Airhart, Nima Badie, Mark Doyle, Priscilla Correa-Jacque, Curt Daniels, and Raymond Benza
Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production., Alejandro F Alice, Gwen Kramer, Shelly Bambina, Keith S Bahjat, Michael J Gough, and Marka R Crittenden
Reply: Transcarotid trumps transapical/direct aortic access for transcatheter aortic valve replacement-It's a no brainer!, Keith B Allen, Adnan K Chhatriwalla, John Saxon, James Hermiller, David Heimansohn, Sina Moainie, Raymond G McKay, Mohiuddin Cheema, Brandon Jones, Robert W Hodson, Ethan Korngold, and Eric Kirker
THE BLEEDING RISK TREATMENT PARADOX AT THE PHYSICIAN 1 AND HOSPITAL LEVEL: IMPLICATIONS FOR REDUCING BLEEDING IN PATIENTS UNDERGOING PCI., Amit P Amin, Nathan Frogge, Hemant Kulkarni, Gene Ridolfi, Gregory Ewald, Rachel Miller, Bruce Hall, Susan Rogers, Tyler J Gluckman, Jeptha Curtis, Frederick A Masoudi, and Sunil V Rao
Transradial Access for High-Risk Percutaneous Coronary Intervention: Implications of the Risk-Treatment Paradox., Amit P Amin, Sunil V Rao, Arnold H Seto, Manoj Thangam, Richard G Bach, Samir Pancholy, Ian C Gilchrist, Prashant Kaul, Binita Shah, Mauricio G Cohen, Ty J Gluckman, Anna Bortnick, James T DeVries, Hemant Kulkarni, and Frederick A Masoudi
How to Conduct a High Quality, Interactive Virtual Meeting:: Learnings From Virtual Magnet® Site Visits, Helene M. Anderson, Jennifer Gentry, Kelly McCoy, and Cheryl Schmitt
Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma., Robert H I Andtbacka, Brendan Curti, Gregory A Daniels, Sigrun Hallmeyer, Eric D Whitman, Jose Lutzky, Lynn E Spitler, Karl Zhou, Praveen K Bommareddy, Mark Grose, Meihua Wang, Cai Wu, and Howard L Kaufman
Power & Power-Building in the BHC Initiative: Evaluating Complex, Place-based Initiatives Using Mixed & Integrated Methods, Lisa Angus, Claire Devine, Monique Gill, and Maggie Weller
iNetModels 2.0: an interactive visualization and database of multi-omics data., Muhammad Arif, Cheng Zhang, Xiangyu Li, Cem Güngör, Buğra Çakmak, Metin Arslantürk, Abdellah Tebani, Berkay Özcan, Oğuzhan Subaş, Wenyu Zhou, Brian Piening, Hasan Turkez, Linn Fagerberg, Nathan Price, Leroy Hood, Michael Snyder, Jens Nielsen, Mathias Uhlen, and Adil Mardinoglu
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy)., Paolo A Ascierto, Carlo Bifulco, Fortunato Ciardiello, Sandra Demaria, Leisha A Emens, Robert Ferris, Silvia C Formenti, Jerome Galon, Samir N Khleif, Tomas Kirchhoff, Jennifer McQuade, Kunle Odunsi, Akash Patnaik, Chrystal M Paulos, Janis M Taube, John Timmerman, Bernard A Fox, Patrick Hwu, and Igor Puzanov
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)., Paolo A Ascierto, Christian Blank, Reinhard Dummer, Marc S Ernstoff, Soldano Ferrone, Bernard A Fox, Thomas F Gajewski, Claus Garbe, Patrick Hwu, Pawel Kalinski, Michelle Krogsgaard, Roger S Lo, Jason J Luke, Bart Neyns, Michael A Postow, Sergio A Quezada, Michele W L Teng, Giorgio Trinchieri, Alessandro Testori, Corrado Caracò, Iman Osman, Igor Puzanov, and Magdalena Thurin
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020., Paolo A Ascierto, Joshua Brody, Lisa H Butterfield, Olivera J Finn, John Goldberg, Francesco Perrone, Ryan J Sullivan, Bernard A Fox, Patrick Hwu, and Igor Puzanov
The State of Melanoma: Emergent Challenges and Opportunities., Michael B Atkins, Clara Curiel-Lewandrowski, David E Fisher, Susan M Swetter, Hensin Tsao, Julio A Aguirre-Ghiso, Maria S Soengas, Ashani T Weeraratna, Keith T Flaherty, Meenhard Herlyn, Jeffrey A Sosman, Hussein A Tawbi, Anna C Pavlick, Pamela B Cassidy, Sunandana Chandra, Paul B Chapman, Adil Daud, Zeynep Eroglu, Laura K Ferris, Bernard A Fox, Jeffrey E Gerhsenwald, Geoffrey T Gibney, Douglas Grossman, Brent A Hanks, Douglas Hanniford, Eva Hernando, Joanne M Jeter, Douglas B Johnson, Samir N Khleif, John M Kirkwood, Sancy A Leachman, Darren Mays, Kelly C Nelson, Vernon K Sondak, Ryan J Sullivan, and Glenn Merlino
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial—ECOG-ACRIN EA6134, Michael B. Atkins, Brendan Curti, and See full list of authors in comments
Tips and tricks for invasive assessment of aortic stenosis, Tamara Atkinson, Jayant Bagai, and Crispin Davies
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma., Hani Babiker, Irene Brana, Daruka Mahadevan, Taofeek Owonikoko, Emiliano Calvo, Danny Rischin, Victor Moreno, Kyriakos P Papadopoulos, Marka Crittenden, Silvia Formenti, Jordi Giralt, Pilar Garrido, Ainara Soria, Asunción Hervás-Morón, Kosalai Kal Mohan, Matthew Fury, Israel Lowy, Melissa Mathias, Minjie Feng, Jingjin Li, and Elizabeth Stankevich
Arginase therapy combines effectively with checkpoint blockade or agonist anti-OX40 immunotherapy to control tumor growth., Mark D Badeaux, Annah S Rolig, Giulia Agnello, Danlee Enzler, Melissa Kasiewicz, Leslie Priddy, Jason F Wiggins, Alexander Muir, Mark R Sullivan, Jessica Van Cleef, Christopher Daige, Matthew G Vander Heiden, Venkatesh Rajamanickam, James Wooldridge, William L. Redmond, and Scott W Rowlinson
Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof, Keith Bahjat, Yoshinobu Koguchi, and Alejandro F Alice
Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof, Keith Bahjat, Yoshinobu Koguchi, and Alejandro F Alice
CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy, Keith Sadoon Bahjat, Helena Maria Hoen, Yoshinobu Koguchi, and Alan J. Korman
CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy, Keith Sandoon Bahjat, Helena Maria Hoen, Yoshinobu Koguchi, and Alan J. Korman
Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy., Peng Bai, Yongzheng Li, Qiuping Zhou, Jiaqi Xia, Peng-Cheng Wei, Hexiang Deng, Min Wu, Sanny K Chan, John W Kappler, Yu Zhou, Eric Tran, Philippa Marrack, and Lei Yin
SARS-CoV-2 Antibodies Detected in Mother's Milk Post-Vaccination., Jill K Baird, Shawn M Jensen, Bernard A Fox, Jason R Baird, and Walter J. Urba
SARS-CoV-2 antibodies detected in human breast milk postvaccination, Jill K. Baird, Shawn M. Jensen, Walter Urba, Bernard A Fox, and Jason R Baird
Amivantamab in combination with lazertinib for the treatment of osimertinib-relapsed, chemotherapy-naïve EGFR mutant (EGFRm) non-small cell lung cancer (NSCLC) and potential biomarkers for response., Joshua Bauml, Byoung Chul Cho, Rachel E Sanborn, and See full author list in comments
Age-Friendly Health System Symposium, Don Berwick, Amy Berman, Rod Hochman, Amy Compton-Phillips, Sylvain Trepanier, Jennifer Bayersdorfer, Jaime Eggert, Matthew J Gonzales, Marian O. Hodges, Jordan Roth, Daniel Safranek, and Carrie B Rubenstein
Hospital Librarianship: What’s The New Normal?, Seema Bhakta
The virtual molecular tumor board as a tool for the delivery of precision oncology, Carlo Bifulco
Performance characteristics of the Roche Diagnostics cobas® Liat® PCR System as a COVID-19 screening tool for hospital admissions in a regional healthcare delivery system., Douglas Blackall, Raymond Moreno, Justin Jin, Rachel Plotinsky, Ronald Dworkin, and Margret Oethinger
10. Dendritic cell migration is required for the immunological responsiveness of tumors to radiation therapy, TC Blair, G Kramer, S Bambina, A Dowdell, AF Alice, Brian D. Piening, Marka R Crittenden, and MJ Gough
Fifteen-minute Frequency of Glucose Measurements and the Use of Threshold Alarms: Impact on Mitigating Dysglycemia in Critically Ill Patients., Grant V Bochicchio, Stanley A Nasraway, Laura J Moore, Anthony P Furnary, Eden A Nohra, Kelly M Bochicchio, James C Boyd, David I Bruns, Irl B Hirsch, Jean-Charles Preiser, and James S Krinsley
Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD Registry., Steven M Bradley, Sophia Emmons-Bell, R Kannan Mutharasan, Fatima Rodriguez, Divya Gupta, Gregory Roth, Ty J Gluckman, Rashmee U Shah, Tracy Y Wang, Rohan Khera, Pamela N Peterson, and Sandeep Das
Temporal trends and predictors of surgical ablation for atrial fibrillation in a large western US healthcare system, Scott Brancato, Mansen Wang, Kateri Spinelli, Alison Leiataua, James Brevig, Zachary M DeBoard, Torin P. Fitton, Maheer Gandhavadi, Jonathan P. Piccini, Neil Worrall, and Tyler J Gluckman
Experience in a blood conservation initiative in cardiac surgery, James Brevig, Ruyun Jin, and Matthew Ducsik
165 Generating enhanced tumor infiltrating lymphocytes through microfluidic cell squeezing, Devin Bridgen, Andrew D Weinberg, and See full list of authors in comments
A Randomized Study of Lenvatinib 18 mg Vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer., Marcia S Brose, Yury Panaseykin, Bhavana Konda, Christelle de La Fouchardiere, Brett G M Hughes, Andrew G Gianoukakis, Young Joo Park, Ilia Romanov, Monika K Krzyzanowska, Sophie Leboulleux, Terri A Binder, Corina Dutcus, Ran Xie, and Matthew H Taylor
Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies., Samantha Brown, Jessica A Lavery, Ronglai Shen, Axel S Martin, Kenneth L Kehl, Shawn M Sweeney, Eva M Lepisto, Hira Rizvi, Caroline G McCarthy, Nikolaus Schultz, Jeremy L Warner, Ben Ho Park, Philippe L Bedard, Gregory J Riely, Deborah Schrag, Katherine S Panageas, AACR Project GENIE Consortium, Walter Urba, Brady Bernard, Brian D. Piening, and Carlo Bifulco
A first-in-human study of AO-176, a highly differentiated anti-CD47 antibody, in patients with advanced solid tumors., Howard A. Burris III, Alexander I. Spira, and Matthew H Taylor
Reply to Letter to the Editor on Carotid Artery Velocity., Kari A Campbell, Ann Marie Kupinski, Frank R Miele, Philip F Silva, and R Eugene Zierler
Staying flexible: Adapting fall risk programming, J Caulley and Colleen Casey
Instrument Selection and Application Used to Probe Dental Implants., Joohyun Cha, Chandur Wadhwani, Mansen Wang, Steven D Hokett, and James Katancik
Trends of Femoral Neck Fracture Treatment Using Total Hip Arthroplasty: Reported From the American Joint Replacement Registry., Antonia F Chen, John W Barrington, Paul J Duwelius, James A Browne, Scott M Sporer, Terence Gioe, Kimberly Porter, Peter Hsiue, and Alexandra I Stavrakis
Pulmonary Hypertension And Exercise Intolerance: A Novel Use Of Cardiomems To Measure Hemodynamic Changes In Exercise, Andrew Cheng, Rola Khedraki, Carmen Wheeler, Samantha Bagsic, Orvar Jonsson, Maya Guglin, Mosi Bennett, Jacob Abraham, Ashrith Guha, and Thomas Heywood
Portable air-fed cold atmospheric plasma device for postsurgical cancer treatment., Guojun Chen, Zhitong Chen, Zejun Wang, Richard Obenchain, Di Wen, Hongjun Li, Richard E Wirz, and Zhen Gu
Impact of new cancer therapies on outpatient treatment delivery for colorectal cancer: A population-based study., Leo Chen, Caroline H Speers, Winson Y Cheung, John J Spinelli, and Hagen F Kennecke
Secondary Correction of Midface Fractures., Jonathan Chodroff, Nadir Elias, Michael Whitcomb, Cong Vo, and Richard Bryan Bell
A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance., Erum Chowdhry, Jennifer Moshman, and Stacey Carroll
P2-14-07. Marrow-infiltrating lymphocytes as adoptive immunotherapy for breast cancer, Brie Chun, Nicole E. Fredich, David B Page, and See all authors in comments
94 Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC), Brie Chun, Joanna Pucilowska, Shu-Ching Chang, Isaac Kim, Benjamin Nikitin, Yoshinobu Koguchi, William L. Redmond, Brady Bernard, Venkatesh Rajamanickam, Nathan Polaske, Paul Fields, Valerie Conrad, Mark Schmidt, Walter Urba, Alison Conlin, Heather McArthur, and David B Page
Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC), Brie Chun, Joanna Pucilowska, Shu-Ching Chang, Isaac Kim, Benjamin Nikitin, Yoshinobu Koguchi, William L. Redmond, Brady Bernard, Venkatesh Rajamanickam, Nathan Polaske, Paul Fields, Valerie Conrad, Mark Schmidt, Walter Urba, Alison Conlin, Heather McArthur, and David B Page
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2., Joseph I Clark, Brendan Curti, Elizabeth J Davis, Howard Kaufman, Asim Amin, Ajjai Alva, Theodore F Logan, Ralph Hauke, Gerald P Miletello, Ulka Vaishampayan, Douglas B Johnson, Richard L White, Peter H Wiernik, and Janice P Dutcher
Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison., Stanley Cohan, Jinender Kumar, Stella Arndorfer, Xuelian Zhu, Marko Zivkovic, and Tom Tencer
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)., Stanley L Cohan, Barry A Hendin, Anthony T Reder, Kyle Smoot, Robin Avila, Jason P Mendoza, and Bianca Weinstock-Guttman
Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis., Stanley Cohan, Tom Tencer, Stella Arndorfer, Xuelian Zhu, Marko Zivkovic, and Jinender Kumar
Major disparities in COVID-19 test positivity for patients with non-English preferred language even after accounting for race and social factors in the United States in 2020., Hannah Cohen-Cline, Hsin-Fang Li, Monique Gill, Fatima Rodriguez, Tina Hernandez-Boussard, Harry Wolberg, Jacob Lippa, and Keri B Vartanian
Interim results of viagenpumatucel-L (HS-110) plus nivolumab in previously treated patients (pts) with advanced non-small cell lung cancer (NSCLC) in two treatment settings., Roger B. Cohen, George E. Peoples, Rachel E Sanborn, and See list of authors in comments
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors., Kevin Conlon, Dionysios C Watson, Thomas A Waldmann, Antonio Valentin, Cristina Bergamaschi, Barbara K Felber, Cody J Peer, William D Figg, E Lake Potter, Mario Roederer, Douglas G McNeel, John A Thompson, Sumati Gupta, Rom Leidner, Andrea Wang-Gillam, Nehal S Parikh, Debby Long, Sema Kurtulus, Lang Ho Lee, Niladri Roy Chowdhury, Florent Bender, and George N Pavlakis
Healthier Oregon Qualitative Study, CORE (Center for Outcomes Research & Education)
Facebook Live: Design considerations pre- and post-COVID, Erin Couch and John Milne
Combinations of stereotactic radiotherapy and immune checkpoint inhibition: Translational analyses, Marka R Crittenden
Integrating Radiation Therapy with Immunotherapy, Marka R Crittenden
